Your browser doesn't support javascript.
loading
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Lamar, Zanetta S; Fino, Nora; Palmer, Jodi; Gruber, Lindsey; Morris, Bonny B; Raetskaya-Solntseva, Olga; Kennedy, LeAnne; Vaidya, Rakhee; Hurd, David; Zamkoff, Kenneth.
Afiliação
  • Lamar ZS; Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC; Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC. Electronic address: zlamar@wakehealth.edu.
  • Fino N; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
  • Palmer J; Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
  • Gruber L; Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
  • Morris BB; Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.
  • Raetskaya-Solntseva O; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC.
  • Kennedy L; Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
  • Vaidya R; Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC; Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.
  • Hurd D; Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC; Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.
  • Zamkoff K; Section of Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Clin Lymphoma Myeloma Leuk ; 16(2): 76-81, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26725264

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Rituximab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Rituximab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
...